Your search returned 3 results.

Results
	1.	Low-molecular-weight heparin or dual antiplatelet therapy is more effective than aspirin alone in preventing early neurological deterioration and improving the 6-month outcome in ischemic stroke patients. [electronic resource] by Yi, Xingyang Chi, Wanzhang Wang, Chun Zhang, Biao Lin, Jing Producer: 20150128 In: Journal of clinical neurology (Seoul, Korea) vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke. [electronic resource] by Yi, Xingyang Lin, Jing Wang, Chun Zhang, Biao Chi, Wanzhang Producer: 20150406 In: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome. [electronic resource] by Yi, Xingyang Lin, Jing Wang, Chun Zhang, Biao Chi, Wanzhang Producer: 20150223 In: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search